Biomarin Pharmaceutical Inc (BMRN) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biomarin Pharmaceutical Inc  (NASDAQ: BMRN)


Biomarin Pharmaceutical Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Biomarin Pharmaceutical Inc's ROA in the second quarter of 2026?
Biomarin Pharmaceutical Inc achieved a return on average assets (ROA) of 0.82 % in its second quarter of 2026, this is above BMRN's average return on assets of -0.52%.
Biomarin Pharmaceutical Incs assets during the 12 months ending in the second quarter of 2026 are valued at $8 billion

ROA decreased relative to the period ending Mar 31 2026, due to the decline in net income.

However, within the Healthcare sector 203 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 1436 to 1493.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 57.19 % 20.16 % 8.65 % 11.12 % 5.5 %
Y / Y Net Income Change -81.39 % -43.17 % - - 124.43 %
Net Income (TTM) in million 73 269 349 520 657
Return On Assets (TTM) 0.82 % 3.44 % 4.68 % 7.13 % 9.24 %
BMRN's Total Ranking # 1493 # 1436 # 867 # 677 # 846
Total Assets (TTM) in million 11,723 8,591 7,594 7,616 7,458
Seq. Total Assets Change 36.46 % 13.13 % -0.29 % 2.12 % 4.31 %
Seq. Net Income Change -57.58 % - - - 29.54 %

BMRN's 5 Years Annual ROA >> Back to BMRN Management Effectiveness >> Compare BMRN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 68
Sector # 204
Overall # 2300

Return On Assets Statistics
High Average Low
19.07 %
-0.52 %
-16.91 %
(Mar 31 2011)   (Dec 31 2016)





Financial Statements
Biomarin Pharmaceutical Inc's Assets $ 11,723 million BMRN's Balance sheet
Biomarin Pharmaceutical Inc's Income $ 45 million Quarterly BMRN's Income Statement
BMRN's Income by Division See BMRN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 15.7 % 2.15 % 7.29 % 6.23 % 2.66 %
Total Assets in million 8,086 6,989 6,842 6,377 6,003
Y / Y Net Income Change -18.26 % 154.62 % 18.43 % - -
Net Income in million 349 427 168 142 -64
Annual Return On Assets 4.31 % 6.11 % 2.45 % 2.22 % -1.07 %

BMRN's 5 Years Annual ROA >> Back to BMRN Management Effectiveness >> Compare BMRN ROA to its Competitors



Comment on BMRN's ROA in the fiscal year ending 2025
In the fiscal year 2025 Biomarin Pharmaceutical Inc's ROA decreased compared to previous year to 4.31 %, due to deterioration of net income -18.26 % to $348.90 million, from $426.86 million a year ago, as BMRN's assets were $8,086.26 million.


More Return On Assets Ratios
BMRN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BMRN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BMRN's Competitors
Subscribers only: Roa for Biomarin Pharmaceutical Inc's Suppliers
Subscribers only: Return On Assets for BMRN's Customers

You may also want to know
BMRN's Roi BMRN's Inventory Turnover Ratio BMRN's Growth Rates BMRN's Dividend Comparisons
BMRN's Profitability Ratios BMRN's Asset Turnover Ratio BMRN's Dividend Growth
BMRN's Roe BMRN's Valuation Ratios BMRN's Financial Strength Ratios BMRN's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %
Arvinas Inc   1.29 %
Pacira Biosciences inc   1.17 %
Waters Corporation  1.12 %
Cormedix Inc   1.11 %
Warby Parker Inc   1.05 %
Surgery Partners Inc   1.02 %
Staar Surgical Co  0.84 %
Biomarin Pharmaceutical Inc  0.82 %
Icu Medical Inc  0.75 %
Lifemd Inc   0.65 %
Radnet Inc   0.50 %
Delcath Systems Inc   0.42 %

Date modified: 2026-09-12T06:12:52+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.